home / press / releases

Menu
  • Search all tables

releases: https://www.shaheen.senate.gov/news/press/insulin-act-co-leads-applaud-legislations-advancement-to-key-committee

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://www.shaheen.senate.gov/news/press/insulin-act-co-leads-applaud-legislations-advancement-to-key-committee INSULIN Act Co-Leads Applaud Legislation’s Advancement to Key Committee 2026-07-16 2026 2026-07 Democrat Senate NH Jeanne Shaheen S001181 www.shaheen.senate.gov shaheen https://www.shaheen.senate.gov/news/press scraper (Washington, DC) – U.S. Senators Jeanne Shaheen (D-NH), Susan Collins (R-ME), Reverend Raphael Warnock (D-GA) and John Kennedy (R-LA) applauded the inclusion of their bipartisan INSULIN Act in the Senate Health, Education, Labor and Pensions (HELP) Committee markup next week. The bipartisan legislation to cap the monthly out-of-pocket cost of insulin at $35 enjoys strong bipartisan support, with 14 Senators from each party backing the bill. “We are pleased to see that our bipartisan legislation to make insulin more affordable will come before the Senate HELP Committee for consideration next week,” said Senators Shaheen, Collins, Warnock and Kennedy. “With our constituents crying out for financial relief, our bipartisan bill represents an immediate step Congress can take with overwhelming bipartisan support to lower costs for the millions of Americans who need insulin each and every day just to survive. We strongly urge our colleagues on the HELP Committee to vote in favor of advancing the INSULIN Act in its entirety, which is sorely needed to lower costs for Americans with diabetes, regardless of their insurance status.” Polling released last month from the American Diabetes Association found that 40% of respondents who rely on insulin report paying more than $150 per month for insulin, and 76% of respondents across political parties support a $35 limit on cost sharing for insulin. The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act would cap the monthly out-of-pocket cost of insulin at $35 for Americans on private and employer-sponsored insurance and create a pilot program to provide insulin at the same cost to Americans without insurance. In addition to Shaheen, Collins, Warnock and Kennedy, the legislation is supported by U.S. Senators Jacky Rosen (D-NV), Tommy Tuberville (R-AL), Angus King (I-ME), Lisa Murkowski (R-AK), Mark Kelly (D-AZ), Chuck Grassley (R-IA), Tammy Baldwin (D-WI), Katie Britt (R-AL), Chris Coons (D-DE), Roger Wicker (R-MS), Shelley Moore Capito (R-WV), Tim Kaine (D-VA), Jim Justice (R-WV), Lisa Blunt Rochester (D-DE), Joni Ernst (R-IA), John Hickenlooper (D-CO), Kevin Cramer (R-ND), Angela Alsobrooks (D-MD), Cindy Hyde-Smith (R-MS), Catherine Cortez Masto (D-NV), Jim Banks (R-IN), Cory Booker (D-NJ), Dave McCormick (R-PA) and Elissa Slotkin (D-MI). ### 1 2026-07-17T07:15:58Z 2026-07-17T07:17:05Z
Powered by Datasette · Queries took 2.165ms · Data license: MIT · Data source: dwillis/congress-press